Literature DB >> 12143129

[Growth stimulation of human osteoblast-like cells by thrombocyte concentrates in vitro].

G Weibrich1, S H Gnoth, M Otto, T E Reichert, W Wagner.   

Abstract

AIM OF THE STUDY: Thrombocytes contain different growth factors. Their potential use for increasing bone regeneration is currently under discussion. Basic data about the biologic effect of platelet concentrates (platelet-rich plasma, PRP) are still lacking. This study analyzes the in vitro effect of PRP on the proliferation rate of human osteoblast-like cells (OLC). MATERIAL AND
METHOD: Human OLC were stimulated with thrombocytes in different dilutions (0-1,700,000 thrombocytes/microliter). Three days later a WST test (Roche Diagnostics) was performed to measure the mitochondrial syntheses and cellular proliferation rate.
RESULTS: The proliferation rate of the OLC was (concentration-dependent) increased up to a certain plateau by adding thrombocytes. Further stimulation led to a slight decrease in the proliferation rate. The statistical analysis of the extinction measurements showed significant differences in the cell proliferation rates between mostly all thrombocyte concentration groups (p < 0.0001). Moreover, a statistically significant difference was evaluated for the time-dependent change in extinction (0-5 h) (p < 0.0001).
CONCLUSION: This study shows that the proliferation rate of human OLC can be stimulated in vitro by concentration-dependent platelet concentrates. This in vitro result supports the currently discussed assumption that the clinical use of PRP might increase bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12143129     DOI: 10.1007/s10006-002-0367-6

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  8 in total

1.  [Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?].

Authors:  M Hakimi; P Jungbluth; S Thelen; M Betsch; W Linhart; S Flohé; J Windolf; M Wild
Journal:  Unfallchirurg       Date:  2011-11       Impact factor: 1.000

2.  Treatment of through-and-through bone lesion using autologous growth factors and xenogeneic bone graft: a case report.

Authors:  Silvio Taschieri; Gabriele Rosano; Tommaso Weinstein; Monica Bortolin; Massimo Del Fabbro
Journal:  Oral Maxillofac Surg       Date:  2010-10-23

3.  Platelet Rich Plasma for Traumatic Non-Union Fractures: A Novel butControversial Bone Regeneration Strategy.

Authors:  Fariborz Ghaffarpasand; Maryam Dehghankhalili; Mostafa Shahrezaei
Journal:  Bull Emerg Trauma       Date:  2013-07

4.  Treatment of endodontically induced periapical lesions using hydroxyapatite, platelet-rich plasma, and a combination of both: An in vivo study.

Authors:  C Vaishnavi; B Mohan; L Lakshmi Narayanan
Journal:  J Conserv Dent       Date:  2011-04

5.  Reduction in post extraction waiting period for dental implant patients using plasma rich in growth factors: an in vivo study using cone-beam computed tomography.

Authors:  Varun Arya; Vijay Laxmy Malhotra; Jk Dayashankara Rao; Shruti Kirti; Siddharth Malhotra; Radhey Shyam Sharma
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-10-30

6.  Efficacy of Sticky Bone as a Novel Autologous Graft for Mandibular Third Molar Extraction Socket Healing - An Evaluative Study.

Authors:  Taher Abbas Rupawala; Shital Mayank Patel; Naiya Hitesh Shah; Kunj Bhupeshchandra Sanghvi; Sanjay Vinubhai Makwana; Kruna Kantilal Bhimani
Journal:  Ann Maxillofac Surg       Date:  2020-12-23

7.  Concentration of platelets and growth factors in platelet-rich plasma from Goettingen minipigs.

Authors:  Pascal Jungbluth; Jan-Peter Grassmann; Simon Thelen; Michael Wild; Martin Sager; Joachim Windolf; Mohssen Hakimi
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-11-24

8.  Use of a biological reactor and platelet-rich plasma for the construction of tissue-engineered bone to repair articular cartilage defects.

Authors:  Huibo Li; Shui Sun; Haili Liu; Hua Chen; Xin Rong; Jigang Lou; Yunbei Yang; Yi Yang; Hao Liu
Journal:  Exp Ther Med       Date:  2016-05-23       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.